Anti-Infliximab ELISA Kit

PRINCIPLE OF THE ASSAY This assay employs the quantitative sandwich enzyme immunoassay technique. Infliximab has been pre-coated onto a microplate. Samples or standards are pipetted into microwells and Anti-Infliximab will be captured by immobilized Infliximab. After washing away any unbound substances, a biotin-labeled Infliximab is added to the wells. After washing away any unbound substances, Streptavidin-HRP is added to the wells. Following a wash to remove any unbound enzyme reagent, a substrate solution is added to the wells and color develops in proportion to the amount of Anti-Infliximab bound in the initial step. The color development is stopped and the intensity of the color is measured.

TA-650, cA2, CAS: 170277-31-3

When the kit was stored at the recommended temperature for 6 months, the signal intensity decreased by less than 20%.

2-8 °C

For Research Use Only.